A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. (Record no. 29941633)

MARC details
000 -LEADER
fixed length control field 02408 a2200709 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518052218.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202009s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2045-7634
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/cam4.2425
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hu, Zishuo Ian
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200902
245 00 - TITLE STATEMENT
Title A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer medicine
Date of publication, distribution, etc. 09 2019
300 ## - PHYSICAL DESCRIPTION
Extent 5148-5157 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Albumins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Management
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Targeted Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paclitaxel
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatic Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, Notch2
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, Notch3
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gemcitabine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bendell, Johanna C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bullock, Andrea
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name LoConte, Noelle K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hatoum, Hassan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ritch, Paul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hool, Hugo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leach, Joseph W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanchez, James
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sohal, Davendra P S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Strickler, John
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patel, Ravindranath
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang-Gillam, Andrea
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Firdaus, Irfan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yu, Kenneth H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kapoun, Ann M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Holmgren, Eric
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhou, Lei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dupont, Jakob
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Picozzi, Vincent
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sahai, Vaibhav
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Reilly, Eileen M
773 0# - HOST ITEM ENTRY
Title Cancer medicine
Related parts vol. 8
-- no. 11
-- p. 5148-5157
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/cam4.2425">https://doi.org/10.1002/cam4.2425</a>
Public note Available from publisher's website

No items available.